K+S AG NA O.N.
Commented by André Will-Laudien on June 16th, 2026 | 07:25 CEST
USA–Iran: The Strait of Hormuz is Opening Up! A Sector Buy Signal for Bayer, MustGrow, BASF and K+S!
Created and published on behalf of MustGrow Biologics Corp.
Some things are ultimately not surprising. The "agreement" between the USA–Israel and Iran resembles shadow boxing. One step forward, one step back—that is how the movements at the trading desk appear. The stock markets are reacting accordingly. At the start of the week, optimism about a near-term end to the hostilities is once again dominating. Oil prices are correcting most sharply, down nearly 5%, with Brent now quoted at only USD 82.50 per barrel. This is a positive signal for chemical- and transport-oriented industries in the food sector, with BASF and Bayer showing corresponding strength. Large volumes of goods must be transported globally, and shipping routes carry significant operational importance. As part of efforts to ensure long-term food security, more and more ideas are emerging that could mitigate the international energy crisis. MustGrow focuses on natural ingredients rather than chemicals, while K+S represents a typical example of the "old economy" in this sector. For investors, multiple opportunities for returns are available!
Read
Commented by André Will-Laudien on June 2nd, 2026 | 06:55 CEST
Stock Market Rotation Beyond AI: Opportunities in MustGrow, Bayer, and Novo Nordisk; Caution with K+S
Created and published on behalf of MustGrow Biologics Corp.
A shift in perspective remains the order of the day. Yesterday, the ECB met to discuss the current situation regarding inflation and interest rates. With an inflation rate of over 3% in Europe, there is likely no room for downward interest rate adjustments—quite the opposite! The 10-year yield on German government bonds has settled near the 3% mark over the past four weeks, while in the US, the 30-year yield is already above 5%. In the past, these were warning signs for a currently well-valued NASDAQ, as the so-called trailing P/E ratio has soared from 28 to 36. Growth companies, mostly financed through equity, thrive on tech euphoria, whereas capital-intensive industries, such as the life sciences sector, face a different situation. For example, Bayer and Novo Nordisk do not require market financing, as they hold large cash reserves. In the case of K+S, the ability to pass on prices to end customers could lead to rising cash flows, while the Canadian company MustGrow has only recently raised funds and is steadily continuing its rollout in the US. Mid-term investors should focus on sector rotation when tech momentum fades. The chances of a revival in neglected sectors look strong!
Read
Commented by Armin Schulz on May 28th, 2026 | 08:30 CEST
Bayer, MustGrow Biologics, K+S: The Secret Formula for Success Behind the Biological Fertilizer Revolution
Created and published on behalf of MustGrow Biologics Corp.
The global fertilizer industry is undergoing its most significant structural transformation in generations. A growing global population, technological breakthroughs in biological agricultural solutions, and policy shifts toward more sustainable agriculture are driving this growth sector. The need for more efficient nutrient use is giving rise to a dynamic market with fresh revenue potential. Companies that pursue the right strategies now are positioning themselves for the coming decade. Three players from different worlds embody this development in their own way: Bayer, MustGrow Biologics, and K+S.
Read
Commented by André Will-Laudien on May 7th, 2026 | 08:25 CEST
Moving Ahead with Strong Concepts and Easing Tensions in the Middle East! MustGrow, K+S, Evotec, and Novo Nordisk in Focus
Created and published on behalf of MustGrow Biologics Corp.
What a headline: An agreement between the US and Iran – markets up 2% in just one minute! It can happen that fast. For investors, this is welcome news, as a de-escalation in the Iran conflict would significantly ease global supply chains and reduce pressure on critical transport routes. In particular, the Strait of Hormuz would lose some of its significance as a geopolitical risk factor, potentially stabilizing global flows of goods and energy. Easing tensions are also likely to lower transport costs again, shorten delivery times, and dampen price volatility. For companies in the food, healthcare, and agricultural technology sectors, this creates greater planning certainty and new growth opportunities. MustGrow Biologics and K+S could benefit from more stable agricultural markets, while Evotec and Novo Nordisk may gain additional tailwinds in a calmer healthcare environment. Investors are increasingly turning to stocks that promise sustainable growth and reliable returns in a more stable market setting. The key question now: will volatility finally decline as well?
Read
Commented by Fabian Lorenz on April 24th, 2026 | 07:05 CEST
SHOCK AND OPPORTUNITY: Nel ASA, K+S, and Bayer Partner MustGrow - Which Stock Stands Out?
When will MustGrow Biologics finally break out? In reality, it may only be a matter of time. The Canadians replace conventional fertilizers with mustard-based solutions. In the United States, regulatory approvals have already been obtained. There alone, the revenue potential is estimated at USD 100 million. The company is currently valued at only around CAD 35 million. To unlock global potential, it has brought in partners including Bayer. As a result, the stock appears significantly undervalued. For K+S, valuation is becoming the issue. Despite surprisingly strong numbers, analysts see no further upside potential. Nel ASA has also released its results. However, the hydrogen specialist appears to have rather shocked its shareholders. The development is concerning, and the share price drop of over 10% may only be the beginning of further weakness.
Read
Commented by André Will-Laudien on April 21st, 2026 | 06:55 CEST
Middle East Conflict Weighs on Markets: Food Supply Chains Become a Key Issue – MustGrow, K+S, Evotec, and BioNTech in the Spotlight
The Middle East conflict is once again bringing global supply chains into focus and increasing pressure on vulnerable supply routes. The Strait of Hormuz, in particular, remains a key geopolitical risk factor because it is of great importance for the global flow of goods and energy. If tensions arise there, transportation costs, delivery times, and price fluctuations can quickly escalate. This creates new opportunities as well as risks, particularly for companies involved in food, health, and agricultural technology. MustGrow and K+S ensure the global food supply through fertilizers, while Evotec and BioNTech operate in the complex landscape of health-related issues. Despite uncertain conditions, dynamic investors are keeping an eye on the stocks that deliver comparatively robust results in a volatile market environment. We dig a little deeper!
Read
Commented by André Will-Laudien on April 7th, 2026 | 07:35 CEST
Fertilizer Crisis: Supply Chain Collapse Threatens Bayer, Nestlé, MustGrow, and K+S! Where are the Opportunities for Investors?
The escalation involving Iran has thrown global supply chains and the fertilizer and food sectors into a state of emergency, as sanctions and security risks are crippling exports of key raw materials. Iran, a key producer of phosphate-based fertilizers and potash products, is temporarily out of the picture, leading to price spikes of up to 40% in the agricultural sector. Bayer is struggling with rising production costs for its agrochemicals division, which is putting extreme pressure on margins. Even Nestlé is increasingly facing raw material shortages for animal feed and packaging materials. The situation regarding supply security in Europe is at risk in the medium term, as inflationary pressure on food prices is noticeably increasing. MustGrow is positioning itself as a game-changer with organic fertilizer alternatives that are scalable regardless of geopolitical hotspots and promise rapid revenue growth. Kali + Salz is benefiting massively from the demand for potash fertilizer, as European inventories shrink and demand from agriculture explodes.
Read
Commented by Mario Hose on March 25th, 2026 | 07:00 CET
The Mustard Revolution Is Here! How the Newcomer MustGrow Is Challenging Giants Bayer and K+S
We may already be, or soon find ourselves, at a dangerous crossroads in world history, where the mere availability of food becomes a decisive factor of power. While headlines are dominated by blocked shipping routes like the Strait of Hormuz and fertilizer shortages, a new alliance for supply security is forming on the stock market. Companies such as Bayer and K+S find themselves in a technical chart situation that raises only one key question: Is this a good entry opportunity? At the same time, the innovative pioneer MustGrow Biologics is preparing to disrupt the market from the ground up with its patented mustard-based technology. In this report, we analyze why the combination of established chemical power, strategic raw materials, fertilizers, and a biological revolution could stabilize your portfolio right now. Those who fail to take a closer look may miss the moment when the course for the coming years is set.
Read
Commented by Armin Schulz on March 20th, 2026 | 08:20 CET
Fertilizer Crisis Triggered by the Iran War: Why Bayer, MustGrow Biologics, and K+S Offer the Perfect Portfolio Mix
When bombs fall in the Persian Gulf, the global agricultural economy trembles. The recent military strikes against Iran have thrown the fertilizer markets into turmoil. Prices for nitrogen and ammonia are skyrocketing, and shares of North American corporations are surging by double digits. Regardless of the acute geopolitical upheaval, the industry is undergoing a fundamental transformation. While one half of the sector is still cashing in on the short-term gains from the crisis, the other has long been driving forward the vision of sustainable agriculture, spurred by regulatory pressure. Three companies show where the journey is headed: agricultural giant Bayer, agricultural biotechnology company MustGrow Biologics, and fertilizer specialist K+S.
Read
Commented by Nico Popp on March 16th, 2026 | 07:25 CET
Energy Crisis Drives Agricultural Transformation: Opportunities in MustGrow Biologics, K+S, and Corteva Agriscience
Agriculture is at a turning point. The reason is the renewed escalation in the Middle East. The Strait of Hormuz, through which roughly one-fifth of global liquefied natural gas shipments and significant volumes of fertilizer-related trade pass, represents one of the world's most critical energy chokepoints. The resulting instability has pushed energy prices higher and stalled the production of synthetic nitrogen fertilizers. Since natural gas is the base raw material for fertilizer production, agricultural companies and farmers must rethink their strategies. In this environment, agricultural innovation will play a crucial role in securing future food supply. Companies such as K+S and Corteva Agriscience are responding to cost pressures in energy raw materials, while MustGrow Biologics is attracting attention with biological solutions that could reduce reliance on synthetic fertilizers.
Read